You are here: Industry Insights > COVID-19

News List

Latest developments in epidemic control on March 12 (1) chinadaily
March 12, 2020
Wuhan allows businesses that support the supply of medical resources, daily necessities, and agricultural materials to return to work. Enterprises that are related to the national economy, people's livelihood, and the global industrial chain are also enco
Last developments in epidemic control on March 12 (2) chinadaily
March 12, 2020
Here are the latest developments on the novel coronavirus disease (COVID-19) in China.
China says COVID-19 peak is over chinadaily
March 12, 2020
The peak of the current outbreak of novel coronavirus disease (COVID-19) in China is over, a spokesperson of the National Health Commission said on March 12.
Mount Sinai and Harbour BioMed collaborate to advance novel biotherapies to treat cancer and coronavirus COVID-19 pharmaceutical-business-review
March 12, 2020
Mount Sinai Health System and Harbour BioMed (HBM) have entered into a multi-year, multifaceted collaboration to develop novel, fully human antibodies for the treatment and prevention of various diseases including oncology and immunology.
Novavax secures CEPI funding for Covid-19 vaccine pharmaceutical-technology
March 12, 2020
Novavax has received initial funding of $4m from the Coalition for Epidemic Preparedness Innovations (CEPI) for the development of a Covid-19 vaccine.
Sanofi and Regeneron to assess Kevzara to treat Covid-19 pharmaceutical-technology
March 12, 2020
Sanofi and Regeneron Pharmaceuticals have plans to initiate clinical trials of rheumatoid arthritis drug Kevzara for the treatment of Covid-19 symptoms.
CEL-SCI to develop Covid-19 immunotherapy pharmaceutical-technology
March 12, 2020
Biotechnology company CEL-SCI has begun efforts to develop an immunotherapy for the potential treatment of Covid-19 coronavirus infection.
Integral Molecular to work on coronavirus vaccine research pharmaceutical-technology
March 12, 2020
US-based biotechnology company Integral Molecular will leverage its technology platforms to identify Covid-19 vaccines and therapeutics.
Wellcome, Gates Foundation, Mastercard focus on Covid-19 therapies pharmaceutical-technology
March 12, 2020
Wellcome has partnered with the Bill & Melinda Gates Foundation and Mastercard to provide up to $125m of seed funding to accelerate the development of Covid-19 therapies.
Serum Institute plans COVID-19 vaccine by 2022 expresspharma
March 12, 2020
States the need for fast-tracking of regulatory clearances for the vaccine.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 437 438 Next page